Exelixis

$24.75
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.24 (+0.98%) As of 5:41 PM UTC today

Why Robinhood?

You can buy or sell Exelixis and other stocks, options, and ETFs commission-free!

About EXEL

Exelixis, Inc. Common Stock, also called Exelixis, is a biopharmaceutical company, which engages in the development, commercialization, and discovery of new medicines for the treatment of cancer.

CEO
Michael M. Morrissey
Employees
773
Headquarters
Alameda, California
Founded
1994
Market Cap
7.79B
Price-Earnings Ratio
67.54
Dividend Yield
—
Average Volume
1.69M
High Today
$24.84
Low Today
$24.30
Open Price
$24.59
Volume
735.43K
52 Week High
$27.80
52 Week Low
$18.18

EXEL Earnings

$0.00
$0.11
$0.23
$0.34
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
— per share
Actual
Expected May 4, After Hours

You May Also Like

RPAY
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure